Cox, Amanda L <br/><br/>
Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.  [electronic resource] 

 -  European journal of immunology  Nov 2005 
 - 3332-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-2980 
<br/><br/><label>Standard No.: </label>10.1002/eji.200535075  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alemtuzumab<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--therapeutic use<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cell Proliferation<br/>Cells, Cultured<br/>Chemokine CCL21<br/>Chemokines, CC--blood<br/>Female<br/>Gene Expression Regulation--immunology<br/>Homeostasis--genetics<br/>Humans<br/>Immunologic Memory--genetics<br/>Interleukin-15--blood<br/>Interleukin-7--blood<br/>Lymphocyte Depletion<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis--immunology<br/>Prospective Studies<br/>Receptors, Interleukin-2--metabolism<br/>Receptors, Interleukin-7--biosynthesis<br/>Th1 Cells--immunology<br/>Th2 Cells--immunology